Replies to post #3349 on BioCurex, Inc.(fka BOCX)

[Kag]

Bocxman,
"They could buy this thing in the open market for a fraction of that."

Gracious sakes alive! BOCX is an illiquid stock and most of the shares are restricted and you say that? What would happen to the stock price if someone tomorrow started buying up a few million share position. Or if someone advertised that they would pay $5 or $10 a share for all your stock?

I don't know what Abbott might be willing to pay for an exclusive serum RECAF license that potentially might be a revenue blockbuster and neither do you. But the real question here is whether Abbott will want to shut out their competitors. They will have that opportunity to do that right up to the time BioCurex sells one of their competitors a semi-exclusive license. kag